BHSRX
Price
$58.29
Change
-$0.05 (-0.09%)
Updated
Apr 17 closing price
Net Assets
6.64B
JFNIX
Price
$64.83
Change
+$0.02 (+0.03%)
Updated
Apr 17 closing price
Net Assets
4.71B
Ad is loading...

BHSRX vs JFNIX

Header iconBHSRX vs JFNIX Comparison
Open Charts BHSRX vs JFNIXBanner chart's image
BlackRock Health Sciences Opps R
Price$58.29
Change-$0.05 (-0.09%)
VolumeN/A
Net Assets6.64B
Janus Henderson Global Life Sciences I
Price$64.83
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets4.71B
BHSRX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BHSRX vs. JFNIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHSRX is a StrongBuy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BHSRX has more cash in the bank: 6.64B vs. JFNIX (4.71B). JFNIX pays higher dividends than BHSRX: JFNIX (0.39) vs BHSRX (0.02). BHSRX was incepted earlier than JFNIX: BHSRX (14 years) vs JFNIX (16 years). BHSRX (1.46) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. BHSRX (27.00). BHSRX has a lower initial minimum investment than JFNIX: BHSRX (100) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -7.78 vs. BHSRX (-9.95). JFNIX return over 5 years is better than : 12.94 vs. BHSRX (-7.89).
BHSRXJFNIXBHSRX / JFNIX
Total Expense Ratio1.460.77190%
Annual Report Gross Expense Ratio1.460.77190%
Fund Existence14 years16 years-
Gain YTD-3.106-4.69066%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets6.64B4.71B141%
Annual Yield % from dividends0.020.395%
Returns for 1 year-9.95-7.78128%
Returns for 3 years-15.70-0.702,253%
Returns for 5 years-7.8912.94-61%
Returns for 10 years7.299.6276%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLSSX11.580.13
+1.14%
Selected International S
ODVNX35.75N/A
N/A
Invesco Developing Markets R
PEOPX51.81N/A
N/A
BNY Mellon S&P 500 Index
SMVIX18.50N/A
N/A
SEI Small Cap Value I (SIMT)
ESERX33.41N/A
N/A
Eaton Vance Atlanta Capital Sel Eq R6